camptothecin has been researched along with Fibrosarcoma in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (52.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asao, Y; Matsuda, H; Miyagawa, K; Nakashima, S; Takayama, S; Xu, F; Yoshida, K; Yoshikawa, M | 1 |
| McHale, AP; Nomikou, N | 1 |
| Li, YS; McHale, AP; Nomikou, N | 1 |
| Huang, H; Huang, J; Liu, S; Xu, H; Yu, J; Zeng, J | 1 |
| Du, F; Huang, J; Liu, S; Lu, W; Luo, Y; Wu, Q; Yu, J | 1 |
| Arizono, Y; Hamada, Y; Naganuma, H; Nakajima, Y; Tasaka, K; Yoshikawa, H | 1 |
| Marchettini, P; Mohamed, F; Stuart, OA; Sugarbaker, PH; Urano, M | 1 |
| Masubuchi, N | 1 |
| Atsumi, R; Iwasaki, D; Morikawa, H; Oguma, T | 1 |
| Kuga, H; Kumazawa, E; Ochi, Y; Shiose, Y | 1 |
| Berrada, M; Dabbarh, F; Gupta, A; Lehnert, S; Owusu, A; Serreqi, A | 1 |
| Benchokroun, Y; Larsen, AK; Lelièvre, S | 1 |
| Comoe, L; Couprie, J; Desoize, B; Grondard, L; Jardillier, JC; Larsen, AK; Riou, JF | 1 |
| Ara, G; Eder, JP; Herman, TS; Holden, SA; Korbut, T; Schwartz, GN; Teicher, BA | 1 |
| Herman, TS; Holden, SA; Khandakar, V; Teicher, BA | 1 |
| Ara, G; Boscia, RE; Holden, SA; Korbut, T; Teicher, BA | 1 |
| Cotter, TG; Samali, A | 1 |
| Holzer, G; Karlseder, J; Orel, L; Simon, MM; Sliutz, G; Tempfer, C | 1 |
| Harstrick, A; Hilger, RA; Rustum, YM; Seeber, S; Vanhoefer, U; Voigt, W; Yin, MB | 1 |
| Adhikari, D; Banerjee, D; Bertino, JR; Fu, JZ; Schnieders, B; Zhao, SC | 1 |
| Katschinski, DM; Robins, HI | 1 |
| Mashima, T; Tsuruo, T; Udagawa, S | 1 |
| Han, R; Lei, X; Liu, H | 1 |
| Khil, MS; Kim, JH; Kim, SH; Kolozsvary, A | 1 |
| Furuta, T; Yokokura, T | 1 |
25 other study(ies) available for camptothecin and Fibrosarcoma
| Article | Year |
|---|---|
Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa.
Topics: Cell Differentiation; Cell Proliferation; Convolvulaceae; Enzyme Precursors; Fibrosarcoma; Flavonoids; Gelatinases; HL-60 Cells; Humans; Matrix Metalloproteinase 9; Metalloendopeptidases; Neoplasm Invasiveness; Plant Extracts; Rotenone; Tumor Cells, Cultured; U937 Cells | 2007 |
Electrokinetic dispersion of a cancer chemotherapeutic drug for the treatment of solid tumours.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Electromagnetic Fields; Fibrosarcoma; Mice; Neoplasm Transplantation; Rats | 2009 |
Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Coloring Agents; Drug Delivery Systems; Evans Blue; Fibrosarcoma; Injections; Mice; Mice, Inbred C3H; Permeability; Time Factors; Tumor Burden; Ultrasonics | 2010 |
Hollow nanosphere fabricated from β-cyclodextrin-grafted α,β-poly(aspartic acid) as the carrier of camptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; beta-Cyclodextrins; Biopolymers; Camptothecin; Cell Survival; Cells, Cultured; Drug Carriers; Drug Compounding; Fibrosarcoma; Mice; Nanospheres; Tumor Cells, Cultured; Water | 2013 |
Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Carriers; Drug Compounding; Fibrosarcoma; Mice; Micelles; Nanoparticles; Polyethylene Glycols; Prodrugs; Surface-Active Agents; Tumor Cells, Cultured | 2013 |
A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Camptothecin; Cell Survival; Cisplatin; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Fibrosarcoma; Flow Cytometry; Glioma; Humans; Membrane Glycoproteins; Osteosarcoma; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2003 |
Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.
Topics: Animals; Antineoplastic Agents; Camptothecin; Deoxycytidine; Drug Screening Assays, Antitumor; Fibrosarcoma; Gemcitabine; Hyperthermia, Induced; Irinotecan; Melphalan; Mice; Mice, Inbred C3H; Organoplatinum Compounds; Oxaliplatin; Paclitaxel | 2003 |
Pharmacokinetics of DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f, in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Camptothecin; Drug Carriers; Fibrosarcoma; Half-Life; Injections, Intravenous; Mice; Mice, Inbred BALB C; Neoplasm Transplantation | 2004 |
Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tan
Topics: Animals; Atmospheric Pressure; Camptothecin; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Fibrosarcoma; Freezing; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Reproducibility of Results; Sensitivity and Specificity | 2005 |
A possible mechanism for the long-lasting antitumor effect of the macromolecular conjugate DE-310: mediation by cellular uptake and drug release of its active camptothecin analog DX-8951.
Topics: Animals; Antineoplastic Agents; Ascites; Camptothecin; Chromatography, High Pressure Liquid; Endocytosis; Fibrosarcoma; Fluorescence; Injections, Intraperitoneal; Lysosomes; Macrophages; Mice; Microscopy, Confocal; Neoplasm Transplantation; Tumor Cells, Cultured | 2005 |
A novel non-toxic camptothecin formulation for cancer chemotherapy.
Topics: Absorbable Implants; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Camptothecin; Cell Line, Tumor; Chitosan; Diffusion; Drug Implants; Fibrosarcoma; Materials Testing; Mice; Mice, Inbred C3H; Treatment Outcome | 2005 |
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Topics: Amsacrine; Animals; Camptothecin; Cell Nucleus; Cricetinae; Cricetulus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance; Etoposide; Fibrosarcoma; Lung Neoplasms; Neoplasm Proteins; Suramin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1995 |
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzophenanthridines; Camptothecin; Catalysis; Cattle; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type II; Drug Resistance; Fibrosarcoma; Intercalating Agents; Leukemia P388; Mice; Phenanthridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Drug Synergism; Female; Fibrosarcoma; Humans; Indazoles; Male; Mice; Mice, Inbred C3H; Novobiocin; Topotecan; Tumor Cells, Cultured | 1993 |
Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Camptothecin; Cell Hypoxia; Cell Survival; Cisplatin; Combined Modality Therapy; Female; Fibrosarcoma; Hydrogen-Ion Concentration; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured | 1993 |
Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Survival; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Resistance; Fibrosarcoma; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred C3H; Topotecan; Tumor Cells, Cultured | 1993 |
Heat shock proteins increase resistance to apoptosis.
Topics: Animals; Apoptosis; Camptothecin; Cell Line; Cell Survival; Dactinomycin; DNA Damage; Etoposide; Fibrosarcoma; Heat-Shock Proteins; Heat-Shock Response; Humans; Mice; Monocytes; Tumor Cells, Cultured | 1996 |
Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Division; Deoxycytidine; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fibrosarcoma; Gemcitabine; HSP70 Heat-Shock Proteins; Humans; Mice; Quercetin; Topotecan; Transfection; Tumor Cells, Cultured | 1996 |
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multid
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Northern; Camptothecin; Carbazoles; Cell Count; Chromatography, High Pressure Liquid; DNA Topoisomerases, Type I; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fibrosarcoma; Glucosides; Humans; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; RNA, Messenger; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1997 |
Role of E2F-1 in chemosensitivity.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Survival; Cloning, Molecular; Culture Media, Serum-Free; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Fibrosarcoma; Humans; Irinotecan; Paclitaxel; Recombinant Proteins; Retinoblastoma-Binding Protein 1; Tetrahydrofolate Dehydrogenase; Transcription Factor DP1; Transcription Factors; Transfection; Tumor Cells, Cultured | 1998 |
Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Cell Division; Cell Nucleus; Cell Survival; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Fibrosarcoma; Hot Temperature; Humans; Hyperthermia, Induced; Irinotecan; Kinetics; Lung Neoplasms; Mice; Topoisomerase I Inhibitors | 1999 |
Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
Topics: Activating Transcription Factor 3; Active Transport, Cell Nucleus; Amino Acid Chloromethyl Ketones; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Camptothecin; Caspase Inhibitors; Caspases; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibrosarcoma; Gene Expression Regulation; HeLa Cells; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Topoisomerase I Inhibitors; Transcription Factors; Transfection; Tumor Cells, Cultured | 2001 |
[Anti-invasion activity of several plant-originated anticancer drugs with different mechanism of action].
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Movement; Fibrosarcoma; Harringtonines; Homoharringtonine; Humans; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Paclitaxel; Plant Bark; Plant Roots; Taxus; Tumor Cells, Cultured | 1998 |
Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I.
Topics: Animals; Camptothecin; Combined Modality Therapy; Fibrosarcoma; HeLa Cells; Humans; In Vitro Techniques; Male; Methylcholanthrene; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Radiation-Sensitizing Agents; Topoisomerase I Inhibitors; Topotecan | 1992 |
[Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative].
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Fibrosarcoma; Injections, Intraperitoneal; Injections, Intravenous; Irinotecan; Leukemia L1210; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental | 1990 |